Table 2.
Distribution of serological markers in the study group.
| Hepatitis B markers (combinatorial serological profile) | Prevalence (N = 2,533) | ||
|---|---|---|---|
| n | % | 95% CI | |
| HBsAg only | 11 | 0.4 | 0.2–0.8 |
| Anti-HBs only | 435 | 17.2 | 15.8–18.7 |
| Anti-HBc only | 100 | 3.9 | 3.3–4.8 |
| HBsAg, anti-HBs | 2 | 0.1 | 0.0–0.3 |
| HBsAg, anti-HBc | 10 | 0.4 | 0.2–0.7 |
| HBsAg, anti-HBs, anti-HBc | 2 | 0.1 | 0.0–0.3 |
| Anti-HBs, anti-HBc | 108 | 4.3 | 3.5–5.1 |
| Any of the following: HBsAg, anti-HBs, anti-HBc | 668 | 26.4 | 24.7–28.1 |
| The aforementioned markers are absent | 1,865 | 73.6 | 71.9–75.3 |